# Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

> **NCT01900444** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 119 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** IMOJEV

## Key facts

- **NCT ID:** NCT01900444
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-11
- **Primary completion:** 2014-03-11
- **Final completion:** 2014-03-11
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900444, "Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01900444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*